| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1993) |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | W31X2H97FB |
| InChI Key | NGBFQHCMQULJNZ-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C16H20N4O3S |
| Molecular Weight | 348.43 |
| AlogP | 2.53 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 100.19 |
| Molecular species | ACID |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 24.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Sodium-(potassium)-chloride cotransporter 2 inhibitor | DailyMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Oxidoreductase
|
- | - | - | - | 14 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 73 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Heart Failure | 4 | D006333 | ClinicalTrials |
| Pre-Eclampsia | 2 | D011225 | ClinicalTrials |
| Diabetes Mellitus, Type 2 | 1 | D003924 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 56211-40-6 |
| ChEBI | 9637 |
| ChEMBL | CHEMBL1148 |
| DrugBank | DB00214 |
| DrugCentral | 2708 |
| EPA CompTox | DTXSID2023690 |
| FDA SRS | W31X2H97FB |
| Human Metabolome Database | HMDB0014359 |
| Guide to Pharmacology | 7312 |
| PharmGKB | PA451733 |
| PubChem | 41781 |
| SureChEMBL | SCHEMBL41184 |
| ZINC | ZINC000000005823 |